Activatable photothermal agents with target-initiated large spectral separation for highly effective reduction of side effects

Photothermal agents (PTAs) with minimized side effects are critical for transforming cancer photothermal therapy (PTT) into clinical applications. However, most currently available PTAs lack true selective activation to reduce side effects because of heavy spectral overlap between photothermal agent...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Jie, Cheng, Ning, Yin, Kai, Wang, Rongchen, Zhu, Tianli, Gao, Jinzhu, Dong, Xuemei, Dong, Chengjun, Gu, Xianfeng, Zhao, Chunchang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society of Chemistry 2022
Materias:
Chemistry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9400798/
https://www.ncbi.nlm.nih.gov/pubmed/36128038
http://dx.doi.org/10.1039/d2sc02467e

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9400798/
https://www.ncbi.nlm.nih.gov/pubmed/36128038
http://dx.doi.org/10.1039/d2sc02467e

Ejemplares similares